However, consistent with the decreased VEGF secretion from gastric cell, phosphorylation of TFAP2A was also significantly decreased in 5-Fluorouracil resistant cells for treatment with EGCG in the parental and resistant gastric cancer cells(Figure 4B). This evidence concerns the gene TFAP2A and gastric cancer.